Helio Genomics partnered with LiverRight, the National Virtual Clinic for Liver Disease — integrating the LiverTrace™ blood-based test with same-week access to board-certified hepatologists in all 50 states.
Combining a breakthrough blood-based test with same-week access to board-certified hepatologists in all 50 states.
IRVINE, Calif., December 15, 2025 /PRNewswire/ — Helio Genomics (“Helio” or “the Company”), an AI-driven techbio company specializing in diagnostics technology for cancer detection, today announced a strategic partnership with LiverRight®, the National Virtual Clinic for Liver Disease in Adults. The partnership integrates Helio’s LiverTrace™ blood-based liver cancer test with LiverRight’s nationwide network of hepatology specialists, creating a seamless pathway from early detection to expert care.
Liver disease affects approximately 1 in 3 U.S. adults, with metabolic dysfunction-associated steatotic liver disease (MASLD) alone impacting roughly 30% of the adult population. MASLD is the leading cause of cirrhosis and liver cancer for women in the United States and the second leading cause for men, yet liver disease remains significantly under-diagnosed, and patients often face months-long delays to see a specialist.
“This partnership represents a new standard in hepatocellular carcinoma (HCC) liver cancer care. When it comes to liver cancer, every week matters—delays in diagnosis can be the difference between a curable condition and a life-threatening battle. By combining the power of LiverTrace’s breakthrough technology with LiverRight’s nationwide network of hepatology specialists, we are ensuring patients have access to a specialist within days, not months.”
How the Partnership Works
LiverTrace uses AI and machine learning to detect cancer biomarkers through a simple blood draw, identifying potential liver cancer even before a tumor is visible through ultrasound. Patients who receive their LiverTrace results can immediately connect with LiverRight’s board-certified hepatologists and hepatology Advanced Practice Providers for expert interpretation and, when relevant, advancement into formal diagnosis and treatment.
“Liver cancer identification has historically started with the patient moving to imaging, specifically a liver MRI. There has never been an essential noninvasive and convenient intervention as a potential on-ramp to imaging, until LiverTrace.”
Convenient, At-Home Testing
LiverTrace is purpose-built for adults at risk for liver cancer, including those with a family history, previous liver issues, or lifestyle factors that increase risk. After ordering, a collection kit is shipped to the patient’s home, and a mobile phlebotomist is scheduled to visit at the patient’s convenience for a professional blood draw. Results are available within fourteen business days through a secure online portal. The LiverTrace website (livertrace.com) includes an eight-question survey for assessing key risk factors.
“When caught early—before the liver tumor is large or has spread—several potentially curative options are available, including liver transplantation. With early-stage diagnosis, five-year survival rates can exceed 70%. In advanced stages, survival drops to months to 1–2 years, even with treatment. Early detection can triple survival chances.”
About Helio Genomics
Helio Genomics is a commercial stage, AI-driven techbio company specializing in diagnostics technology to pioneer cancer early detection and minimal residual disease monitoring. Its advanced blood-based multi-analyte platform uses machine learning and deep learning to detect cancer biomarkers with unprecedented accuracy, empowering clinicians and patients to act swiftly in the fight against liver cancer. Clinically validated in studies with thousands of patients, Helio Genomics is supported by an expanding commercial presence.
About LiverRight
LiverRight is the nation’s first and only National Virtual Clinic focused on liver disease, serving adult patients via telemedicine in all 50 states. Its mission is threefold: getting new patients seen same-week, ensuring early diagnosis, and offering longitudinal care with superior outcomes and lower costs. LiverRight’s team of board-certified hepatologists and hepatology Advanced Practice Providers diagnose and treat all forms of liver disease. For more information, visit liverright.com.
SOURCE Helio Genomics. Contact: Bharat Tewarie, CEO, bharat@heliogenomics.com.